Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 268
Titolo Data di pubblicazione Autore(i) File
TRATTAMENTO MULTIMODALE DEL CANCRO DELL’ESOFAGO TORACICO: STUDIO IN FASE II CON CHEMIO-RADIO TERAPIA E CHIRURGIA 1-gen-1999 DI MARTINO, N; DE VITA, Ferdinando; Cosenza, Angelo; Battista, C; Monaco, L; DEL GENIO, A.
Il trattamento del carcinoma colorettale in fase avanzata: up-date sui nuovi farmaci 1-gen-1999 DE VITA, Ferdinando; Orditura, Michele; Catalano, G.
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 1-gen-1999 Catalano, G.; Roscigno, A.; DE VITA, Ferdinando; Orditura, M.; Infusino, F.; Auriemma, A.; Bontempo, Paola; Tortora, V.; Molinari, Anna Maria; AND SCHIAVONE, E. M.
MULTIMODAL TREATMENT OF THE THORACIC ESOPHAGEAL CANCER: PHASE II STUDY WITH CHEMIO-RADIO THERAPY AND SURGERY 1-gen-1999 DI MARTINO, N; DE VITA, Ferdinando; Cosenza, Angelo; Napolitano, Vincenzo; Battista, C.
La malattia avanzata 1-gen-1999 DE VITA, Ferdinando; Orditura, Michele; Catalano, G.
Cancerogenesi e rischio professionale 1-gen-1999 DE VITA, Ferdinando; Orditura, Michele; Roscigno, A; Catalano, G.
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group 1-gen-1999 Comella, P; Casaretti, R; DE VITA, Ferdinando; Avallone, A; Orditura, Michele; Petrillo, A; Gravina, A; Faranda, A; Comis, S; Comella, G; Catalano, G.
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 1-gen-1999 DE VITA, Ferdinando; Orditura, Michele; Galizia, Gennaro; Romano, Ciro Pasquale; Infusino, S; Auriemma, A; Lieto, Eva; Catalano, G.
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 1-gen-1999 Orditura, Michele; DE VITA, Ferdinando; Ciaramella, F; Roscigno, A; Infusino, S; Auriemma, A; Abbate, G; Catalano, G.
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients. 1-gen-1999 DE VITA, Ferdinando; Orditura, Michele; Auriemma, A; Infusino, S; Catalano, G.
Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer 1-gen-1999 Caponigro, F; Avallone, A; Mcleod, H; Carteni, G; DE VITA, Ferdinando; Casaretti, R; Morsman, J; Blackie, R; Budillon, A; DE LUCIA, L; Gravina, A; Catalano, G; Comella, P; Comella, G.
The new European gold standard treatment for rectum cancer 1-gen-2000 DE VITA, Ferdinando; Orditura, Michele; Martinelli, Erika; Moraca, L; DE CHIARA, A; Catalano, G.
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 1-gen-2000 Orditura, Michele; Romano, Ciro Pasquale; DE VITA, Ferdinando; Galizia, Gennaro; Lieto, Eva; Infusino, S; DE CATALDIS, G; Catalano, G.
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 1-gen-2000 DE VITA, Ferdinando; Orditura, Michele; Galizia, Gennaro; Romano, Ciro Pasquale; Lieto, Eva; Iodice, P; Tuccillo, C; Catalano, G.
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial 1-gen-2000 Comella, P; DE VITA, Ferdinando; Mancarella, S; DE LUCIA, L; Biglietto, M; Casaretti, R; Farris, A; Ianniello, Gp; Lorusso, V; Avallone, A; Carteni, G; Leo, Ss; Catalano, G; DE LENA, M; Comella, G.
Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group 1-gen-2000 Comella, P; DE VITA, Ferdinando; DE LUCIA, L; Casaretti, R; Avallone, A; Orditura, Michele; Rivellini, F; Palmeri, S; Catalano, G; Comella, G.
Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trial 1-gen-2000 Lorusso, V; Manzione, L; DE VITA, Ferdinando; Antimi, M; Selvaggi, Fp; DE LENA, M.
Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients 1-gen-2000 Orditura, Michele; DE VITA, Ferdinando; Belli, A; Ciaramella, F; Musico, M; Ferrigno, A; Formato, R; Abbate, G; Diadema, Mr; Catalano, G.
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 1-gen-2000 DE VITA, Ferdinando; Orditura, Michele; Galizia, Gennaro; Romano, Ciro Pasquale; Roscigno, A; Lieto, Eva; Catalano, G.
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group 1-gen-2000 Lorusso, V; Palmieri, G; Bianco, Ar; Abate, G; Catalano, G; DE VITA, Ferdinando; Dammacco, F; Lauta, Vm; Lucarelli, G; Polimeno, G; Mantovani, G; D'Aprile, M; Marzullo, F; DE LENA, M.
Mostrati risultati da 21 a 40 di 268
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile